US 10906985
Targeted engineered interferon and uses thereof
granted A61KA61K2039/55522A61K38/00
Quick answer
US patent 10906985 (Targeted engineered interferon and uses thereof) held by Orionis Biosciences, Inc expires Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Orionis Biosciences, Inc
- Grant date
- Tue Feb 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2039/55522, A61K38/00, A61K47/60, A61P